Share This Article:

Early onset versus late onset in Alzheimer’s disease: What is the reliable cut-off?

Full-Text HTML Download Download as PDF (Size:274KB) PP. 40-47
DOI: 10.4236/aad.2013.21005    4,455 Downloads   9,148 Views   Citations

ABSTRACT

Objective: As the literature on conventional criteria for discriminating early-onset (EO) from late-onset (LO) Alzheimer’s disease (AD) is sparse and controversial, the aim of this study was to establish a precise age at onset (AAO) criterion, by using a specific statistical procedure, and to describe the clinical characteristics of the two sub-groups. Methods: Admixture analysis was performed to establish the AAO cut-off in a multi-center study including 2000 AD patients consecutively recruited in eight Italian Memory Clinics. None of the patients were taking acetylcholinesterase inhibitors, antipsychoticor anti-depressant drugs. At the first diagnosticvisit, they were administered the Mini Mental StateExamination, the Basic and Instrumental Activities of Daily Living and the Neuropsychiatric Inventorytoassess clinical phenomenology. Results: Using a specific statistical procedure, we established that AAO that discriminated EO-from LO-AD was 66. Compared with the LO-AD group, the EO-AD group showed longer duration of illness and a higher educational level as well as less severe functional impairment and delusions. Conclusions: Differences in sociodemographic and clinical characteristics, such as duration of illness, education and delusion severity, suggested the involvement of different pathogenic processes. Additional studies are needed to further investigate the mechanisms underlying the disorder in the two sub-groups of AD patients.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Spalletta, G., Luca, V., Padovani, A., Rozzini, L., Perri, R., Bruni, A., Canonico, V., Trequattrini, A., Bellelli, G., Pettenati, C., Pazzelli, F., Caltagirone, C. and Orfei, M. (2013) Early onset versus late onset in Alzheimer’s disease: What is the reliable cut-off?. Advances in Alzheimer's Disease, 2, 40-47. doi: 10.4236/aad.2013.21005.

References

[1] APA (2000) Diagnostic and Statistical Manual of Mental Disorder, DSM-IV-TR. Washington. http://www.apa.org/
[2] Reitz, C., Brayne, C. and Mayeux, R. (2011) Epidemiology of Alzheimer disease. Nature Reviews. Neurology, 7, 137-152. doi:10.1038/nrneurol.2011.2
[3] Van der Flier, W.M., Pijnenburg, Y.A., Fox, N.C. and Scheltens, P. (2010) Early-onset versus late-onset Alzheimer’s disease: The case of the missing APOE varepsi- lon4 allele. The Lancet Neurology, 10, 280-288. doi:10.1016/S1474-4422(10)70306-9
[4] Delorme, R., Golmard, J.L., Chabane, N., Millet, B., Krebs, M.O., Mouren-Simeoni, M.C. and Leboyer, M. (2005) Admixture analysis of age at onset in obsessive-compulsive disorder. Psychological Medicine, 35, 237-243. doi:10.1017/S0033291704003253
[5] Hamshere, M.L., Gordon-Smith, K., Forty, L., Jones, L., Caesar, S., Fraser, C., Hyde, S., Tredget, J., Kirov, G., Jones, I., Craddock, N. and Smith, D.J. (2009) Age-at- onset in bipolar-I disorder: Mixture analysis of 1369 cases identifies three distinct clinical sub-groups. Journal of Affective Disorders, 116, 23-29. doi:10.1016/j.jad.2008.10.021
[6] Panariello, F., O’Driscoll, L., De Souza, R.P., Manchia, A. M., Kennedy, J. and De Luca, V. (2010) Age at onset in Canadian schizophrenia patients: Admixture analysis. Schizophrenia Research, 122, 278-279. doi:10.1016/j.schres.2009.10.024
[7] Licht, E.A., McMurtray, A.M., Saul, R.E. and Mendez, M.F. (2007) Cognitive differences between early- and late-onset Alzheimer’s disease. American Journal of Alzheimer’s Disease and Other Dementias, 22, 218-222. doi:10.1177/1533317506299156
[8] Toyota, Y., Ikeda, M., Shinagawa, S., Matsumoto, T., Matsumoto, N., Hokoishi, K., Fukuhara, R., Ishikawa, T., Mori, T., Adachi, H., Komori, K. and Tanabe, H. (2007) Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer’s disease. International Journal of Geriatric Psychiatry, 22, 896-901. doi:10.1002/gps.1760
[9] Van der Vlies, A.E., Koedam, E.L., Pijnenburg, Y.A., Twisk, J.W., Scheltens, P. and Van der Flier, W.M. (2009) Most rapid cognitive decline in APOE epsilon4 negative Alzheimer’s disease with early onset. Psychological Medicine, 39, 1907-1911. doi:10.1017/S0033291709005492
[10] McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939-944. doi:10.1212/WNL.34.7.939
[11] Katz, S., Down, T., Cash, H. and Grotz, R. (1970) Progress in the development of the index of ADL. The Gerontologist, 10, 20-30. doi:10.1093/geront/10.1_Part_1.20
[12] Lawton, M. and Brody, E. (1969) Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist, 9, 179-186. doi:10.1093/geront/9.3_Part_1.179
[13] Morris, J. (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43, 2412- 2414. doi:10.1212/WNL.43.11.2412-a
[14] Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198. doi:10.1016/0022-3956(75)90026-6
[15] Cummings, J.L. (1997) The neuropsychiatric inventory: Assessing psychopathology in dementia patients. Neurology, 48, S10-S16. doi:10.1212/WNL.48.5_Suppl_6.10S
[16] Tozzi, F., Manchia, M., Galwey, N.W., Severino, G., Del Zompo, M., Day, R., Matthews, K., Strauss, J., Kennedy, J.L., McGuffin, P., Vincent, J.B., Farmer, A. and Muglia, P. (2011) Admixture analysis of age at onset in bipolar disorder. Psychiatry Research, 185, 27-32. doi:10.1016/j.psychres.2009.11.025
[17] Small, B.J., Graves, A.B., McEvoy, C.L., Crawford, F.C., Mullan, M. and Mortimer, J.A. (2000) Is APOE-epsilon4 a risk factor for cognitive impairment in normal aging? Neurology, 54, 2082-2088. doi:10.1212/WNL.54.11.2082
[18] Beydoun, M.A., Boueiz, A., Abougergi, M.S., Kitner- Triolo, M.H., Beydoun, H.A., Resnick, S.M., O’Brien, R. and Zonderman, A.B. (2010) Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline. Neurobiology of Aging, 33, 720-731. doi:10.1016/j.neurobiolaging.2010.05.017
[19] Giannattasio, C., Poleggi, A., Puopolo, M., Pocchiari, M., Antuono, P., Dal Forno, G., Wekstein D.R., Matera, M.G., Seripa, D., Acciarri, A., Bizzarro, A., Lauria, A. and Masullo, C. (2008) Survival in Alzheimer’s disease is shorter in women carrying heterozygosity at codon 129 of the PRNP gene and no APOE epsilon 4 allele. Dementia and Geriatric Cognitive Disorders, 25, 354-358. doi:10.1159/000119730
[20] Crawford, F., Abdullah, L., Schinka, J., Suo, Z., Gold, M., Duara, R. and Mullan, M. (2000) Gender-specific association of the angiotensin converting enzyme gene with Alzheimer’s disease. Neuroscience Letters, 280, 215-219. doi:10.1016/S0304-3940(00)00791-6
[21] Picard, C., Pasquier, F., Martinaud, O., Hannequin, D. and Godefroy, O. (2010) Early onset dementia: Characteristics in a large cohort from academic memory clinics. Alzheimer Disease and Associated Disorders, 25, 203-205. doi:10.1097/WAD.0b013e3182056be7
[22] Newens, A., Forster, D., Kay, D., Kirkup, W., Bates, D. and Edwardson, J. (1993) Clinically diagnosed presenile dementia of the Alzheimer type in the Northern Health Region: Ascertainment, prevalence, incidence and survival. Psychological Medicine, 23, 631-644. doi:10.1017/S0033291700025411
[23] Kokmen, E., Chandra, V. and Schoenberg, B.S. (1988) Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology, 38, 975-980. doi:10.1212/WNL.38.6.975
[24] Fairjones, S.E., Vuletich, E.J., Pestell, C. and Panegyres, P.K. (2011) Exploring the role of cognitive reserve in early- onset dementia. American Journal of Alzheimer’s Disease and Other Dementias, 26, 139-144. doi:10.1177/1533317510397328
[25] Serra, L., Cercignani, M., Petrosini, L., Basile, B., Perri, R., Fadda, L., Spano, B., Marra, C., Giubilei, F., Carlesimo, G.A., Caltagirone, C. and Bozzali, M. (2011) Neuroanatomical correlates of cognitive reserve in Alzheimer disease. Rejuvenation Research, 14, 143-151. doi:10.1089/rej.2010.1103
[26] Piras F., Cherubini, A., Caltagirone, C. and Spalletta, G. (2011) Education mediates microstructural changes in bilateral hippocampus. Human Brain Mapping, 32, 282-289. doi:10.1002/hbm.21018
[27] Marshall, G.A., Fairbanks, L.A., Tekin, S., Vinters, H.V. and Cummings, J.L. (2007) Early-onset Alzheimer’s disease is associated with greater pathologic burden. Journal of Geriatrics Psychiatry and Neurology, 20, 29-33. doi:10.1177/0891988706297086
[28] Mortimer, J.A., Borenstein, A.R., Gosche, K.M. and Snowdon, D.A. (2005) Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. Journal of Geriatrics Psychiatry and Neurology, 18, 218-223. doi:10.1177/0891988705281869
[29] Hirono, N., Mori, E., Yasuda, M., Ikejiri, Y., Imamura, T., Shimomura, T., Ikeda, Hashimoto, M.M. and Yamashita, H. (1998) Factors associated with psychotic symptoms in Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 64, 648-652. doi:10.1136/jnnp.64.5.648
[30] Esiri, M.M., Nagy, Z., Smith, M.Z., Barnetson, L. and Smith, A.D. (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet, 354, 919-920. doi:10.1016/S0140-6736(99)02355-7
[31] Geppert, A.M., Wroblewska, K.A. and Przedpelska-Ober, E.M. (2007) Greater frequency of subcortical lesions in severely demented patients with early onset Alzheimer’s disease. Alzheimer’s & Dementia, 3, 54-57. doi:10.1016/j.jalz.2006.10.007
[32] Bella, R., Pennisi, G., Cantone, M., Palermo, F., Pennisi, M., Lanza, G., Zappia, M. and Paolucci, S. (2010) Clinical presentation and outcome of geriatric depression in subcortical ischemic vascular disease. Gerontology, 56, 298-302. doi:10.1159/000272003
[33] Lavretsky, H., Zheng, L., Weiner, M.W., Mungas, D., Reed, B., Kramer, J.H., Jagust, W., Chui, H. and Mack, W. J. (2008) The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. International Journal of Geriatric Psychiatry, 23, 1040-1050. doi:10.1002/gps.2030
[34] Mentis, M.J., Weinstein, E.A., Horwitz, B., McIntosh, A. R., Pietrini, P., Alexander, G.E., Furey, M. and Murphy, D. G. (1995) Abnormal brain glucose metabolism in the delusional misidentification syndromes: A positron emission tomography study in Alzheimer disease. Biological Psychiatry, 38, 438-449. doi:10.1016/0006-3223(94)00326-X
[35] Staff, R.T., Shanks, M.F., Macintosh, L., Pestell, S.J., Gemmell, H.G. and Venneri, A. (1999) Delusions in Alzheimer’s disease: Spet evidence of right hemispheric dysfunction. Cortex, 35, 549-560. doi:10.1016/S0010-9452(08)70818-9
[36] Fujimori, M., Imamura, T., Yamashita, H., Hirono, N., Ikejiri, Y., Shimomura, T. and Mori, E. (1998) Age at on- set and visuocognitive disturbances in Alzheimer disease. Alzheimer Disease and Associated Disorders, 12, 163- 166. doi:10.1097/00002093-199809000-00007
[37] Imamura, T., Takatsuki, Y., Fujimori, M., Hirono, N., Ikejiri, Y., Shimomura, T., Hashimoto, M., Yamashita, H. and Mori, E. (1998) Age at onset and language disturbances in Alzheimer’s disease. Neuropsychologia, 36, 945-949. doi:10.1016/S0028-3932(98)00010-4
[38] Jacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., Lafleche, G., Albert, M., Brandt, J. and Stern, Y. (1994) Age at onset of Alzheimer’s disease: Relation to pattern of cognitive dysfunction and rate of decline. Neurology, 44, 1215-1220. doi:10.1212/WNL.44.7.1215

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.